Breast Biopsy Market size is estimated to be $1.15 billion in 2019, growing at a CAGR of 5.5% during the forecast period 2020-2025.Increasing prevalence of breast cancer among women after menopause, rising population of women and developments in technology is a major factor driving the breast biopsy market during the forecast period 2020-2025.Moreover, the use of stereotactic biopsy in hospitals performed within an hour is further contributing to its market growth. A breast biopsy is a medical procedure in which a sample of breast tissue is removed and sent to the laboratory for testing. In addition a breast biopsy is the best way to evaluate if a suspicious lump or portion of the breast is cancerous. Moreover, according to Effective Health Care Program about one in eight women in the U.S. would develop invasive breast cancer during their lifetime. Approximately 290,000 new cases of breast cancer are diagnosed each year in the U.S. and more than 230,000 of the cases are invasive breast cancer. Furthermore Fine-needle aspiration biopsy is the first pathological diagnosis method used for diagnosis and screening of breast diseases owing to its rapid, safe and less painful procedure.

Key Takeaways

Hospitals accounted for the largest market share in 2019 owing to the increasing number of breast cancer patients around the world.

Increase in Breast Cancer Screening Programs is a major factor fueling the demand of Breast Biopsy Market during the forecast period 2020-2025.

By guided technology, the Ultrasound guided biopsy is poised to be the fastest growing with a CAGR of 4.8% during the forecast period 2020-2025. This is owing to the demand for minimally invasive surgical procedures.

Detailed analysis of the Strength, Weakness, and opportunities of the prominent players operating in the market will be provided in the oxygenator market report.

Request for Sample of the Report @ https://www.industryarc.com/pdfdownload.php?id=501221

Geography- Segment Analysis

North America dominated the Breast Biopsy Market with a region share 36% in 2019 followed by Europe and APAC. Increasing adoption of advanced medical technology and rising development by companies operating on cancer diagnostics is a major factor driving the breast biopsy market during the forecast period 2020-2025.

Drivers –Breast Biopsy Market

1. Rising Number of Breast Cancer Patients
2. Increasing In Breast Cancer Screening Programs

Breast Biopsy Market Industry Outlook : Breast Biopsy Market top 10 companies are Becton, Dickinson, C.R. Bard Inc, Devicor Medical Products Inc, Hologic Inc, Cardinal Health Inc, Angiotech, Galini SRL, Johnson & Johnson and GE Healthcare.

About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to [email protected] to discuss more about our consulting services.